Basic Information
AlmataBio is a developer of humanized monoclonal antibodies designed to bind to interleukin-1β with high affinity and neutralize its activity. The company specializes in producing antibodies that effectively prevent hidradenitis suppurativa and various inflammatory diseases in dermatology, gastroenterology, and rheumatology.
AlmataBio, Inc.
Atlanta,Georgia,United States of America
15~50 people
January 01, 2023
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios